Ratio Examination: Keros Therapeutics Inc (KROS)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.

In the latest session, Keros Therapeutics Inc (NASDAQ: KROS) closed at $54.01 down -4.61% from its previous closing price of $56.62. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 0.57 million shares were traded. KROS stock price reached its highest trading level at $57.01 during the session, while it also had its lowest trading level at $53.72.

Ratios:

For a deeper understanding of Keros Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 19.03 and its Current Ratio is at 19.03. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 13 ’24 when GORDON CARL L sold 250,000 shares for $44.01 per share. The transaction valued at 11,002,500 led to the insider holds 119,522 shares of the business.

ORBIMED ADVISORS LLC sold 250,000 shares of KROS for $11,002,500 on Aug 13 ’24. The Director now owns 119,522 shares after completing the transaction at $44.01 per share. On Aug 13 ’24, another insider, OrbiMed Genesis Master Fund, L, who serves as the Shareholder of the company, bought 29,400 shares for $44.84 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, KROS now has a Market Capitalization of 2187804672 and an Enterprise Value of 1782131456. For the stock, the TTM Price-to-Sale (P/S) ratio is 3157.82 while its Price-to-Book (P/B) ratio in mrq is 3.98. Its current Enterprise Value per Revenue stands at 2737.529 whereas that against EBITDA is -8.784.

Stock Price History:

Over the past 52 weeks, KROS has reached a high of $73.00, while it has fallen to a 52-week low of $27.31. The 50-Day Moving Average of the stock is -9.09%, while the 200-Day Moving Average is calculated to be -2.54%.

Shares Statistics:

For the past three months, KROS has traded an average of 356.50K shares per day and 475850 over the past ten days. A total of 40.51M shares are outstanding, with a floating share count of 32.25M. Insiders hold about 20.38% of the company’s shares, while institutions hold 83.29% stake in the company. Shares short for KROS as of 1730332800 were 2412173 with a Short Ratio of 6.77, compared to 1727654400 on 3017784. Therefore, it implies a Short% of Shares Outstanding of 2412173 and a Short% of Float of 8.1099994.

Most Popular